持续气道正压通气在放射治疗中的获益:一项前瞻性试验
该前瞻性试验纳入40例可分析患者(原发性或继发性肺肿瘤、左侧乳腺癌或肝转移),对比持续气道正压通气(CPAP)与自由呼吸(FB)下的胸部解剖和肿瘤运动。CPAP使平均肺体积增加37%(P < .001),计划靶体积平均减少19%(P < .001),并显著降低肺和心脏剂量学参数。CPAP安全、易实施且多数患者耐受良好。
要点
- CPAP使平均肺体积增加37%,肺V20降低20%、平均肺剂量降低15%。
- CPAP使计划靶体积平均减少19%,下肺肿瘤(膈顶上方6 cm内)获益最大。
- 67.5%患者基于体积或剂量学获益确认后采用CPAP治疗。
核心结论
- CPAP与自由呼吸相比具有显著的体积和剂量学获益,安全、易实施且多数患者耐受良好,应进一步研究以减少肺和心脏毒性风险。
研究设计与样本
- 患者为原发性或继发性肺肿瘤、左侧乳腺癌或肝转移,接受自由呼吸和CPAP两次三维及四维CT模拟。
- CPAP经面罩实施,最大压力15 cm H2O。
主要发现
- 平均肺体积增加37%(P < .001);正常肺功能患者平均增加1283 ± 1128 cm3(P = .0006),限制性通气模式患者增加719 ± 341 cm3(P = .003)。
- 肺体积增加与年龄、体重指数、性别、慢性阻塞性肺疾病、吸烟状态和心脏病无关。
- 计划靶体积平均减少19%(P < .001),肿瘤轨迹和计划靶体积最大降低见于下肺肿瘤,尤其是膈顶上方6 cm范围内。
- 平均肺剂量降低15%,肺V20降低20%,肺V5降低11%,心脏V5降低16%(P < .01)。
临床怎么用
- 对肺肿瘤、左侧乳腺癌或肝转移放疗患者可考虑使用CPAP以增加肺体积、减少肿瘤运动和降低肺心脏剂量。
- 下肺肿瘤(膈顶上方6 cm内)可能从CPAP中获得最大的肿瘤轨迹和计划靶体积降低。
局限性
- 原文未报告长期毒性或临床结局数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: This study aimed to study the impact of continuous positive airway pressure (CPAP) on chest anatomy and tumor motion in patients receiving radiation therapy. METHODS AND MATERIALS: Patients with primary or secondary lung tumors, left-sided breast cancer, or liver metastases referred for radiation therapy were trained to breathe with a CPAP device using a face mask to a maximal pressure of 15 cm H2O. Three- and 4-dimensional computed tomography simulation was performed twice for each patient: once with free breathing (FB) and again using CPAP. Volumetric and dosimetric parameters of treatment plans were compared. RESULTS: Forty-nine patients were enrolled, of whom 6 withdrew consent before simulation and 3 withdrew because of discomfort. Thus, a total of 40 patients were analyzed. Twenty-seven patients (67.5%) were treated with CPAP based on confirmation of the volumetric or dosimetric benefit of CPAP. Mean lung volume increased by 37% (P < .001). The mean augmentation was 1283 ± 1128 cm3 (CPAP vs FB; P = .0006) in patients with normal lung function tests and 719 ± 341 cm3 (P = .003) in patients with a restrictive pattern. Increased lung volume was independent of age, body mass index, sex, chronic obstructive pulmonary disease, smoking status, and heart disease. Tumor motion in the lung was decreased as reflected in a mean reduction of planning target volume by 19% (P < .001). The greatest reduction of tumor trajectory and planning target volume occurred in tumors in the lower lung, particularly in the range of up to 6 cm above the dome of the diaphragm. The mean lung dose was reduced by 15%, lung V20 by 20%, lung V5 by 11%, and heart V5 by 16% (P < .01). CONCLUSIONS: In this prospective trial, the use of CPAP was associated with significant volumetric and dosimetric benefits compared with FB. CPAP was safe, simple to implement, and well tolerated by most patients, and it should be studied further as a method to reduce the risk of lung and heart toxicity.
引用
- Jacobson G, Lawrence YR, Appel S, et al. Benefits of Continuous Positive Airway Pressure (CPAP) During Radiation Therapy: A Prospective Trial. Int J Radiat Oncol Biol Phys. 2021. PMID: 33965269. doi:10.1016/j.ijrobp.2021.03.044
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。